Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use

BACKGROUND: Widespread adoption of genomic technologies in the management of heterogeneous indications, including Multiple Myeloma, has been hindered by concern over variation between published gene expression signatures, difficulty in physician interpretation and the challenge of obtaining sufficie...

Descripción completa

Detalles Bibliográficos
Autores principales: van Laar, Ryan, Flinchum, Rachel, Brown, Nathan, Ramsey, Joseph, Riccitelli, Sam, Heuck, Christoph, Barlogie, Bart, Shaughnessy Jr, John D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032347/
https://www.ncbi.nlm.nih.gov/pubmed/24885236
http://dx.doi.org/10.1186/1755-8794-7-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032347/
https://www.ncbi.nlm.nih.gov/pubmed/24885236
http://dx.doi.org/10.1186/1755-8794-7-25

Ejemplares similares